RU58841 yakında elimde olacak Türkiyede bunu isteyen kimler var? ( I’ll have RU58841 in hand soon; who in Türkiye is interested in it?) Finasteride/Dutasteride 8/2/2026
The conversation is about sourcing RU58841 in Türkiye, with the original poster sharing their positive experience using it for hair loss, noting it reduced shedding without side effects. They plan to distribute it after lab testing, considering customs and pricing challenges.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity So we have 20k dollars human like machines available but no new effective treatment for hairloss since finasteride :)
There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.
community Has anyone seen the data on this 539% boost breakthrough?
Topical Clascoterone showed a 539% improvement in hair count compared to placebo, but its effectiveness and safety are debated. Users compared it to minoxidil and finasteride, with mixed opinions on its potential release in 2026 or 2027.
community PP405 Phase 2a press release with early results
PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.
community Lab results from actifolic RU58841
The post discusses the user's experience with hair loss treatment RU58841, which was tested for quality and found to be 96+% pure. The conversation includes various responses, with some users questioning the safety of the product and others expressing satisfaction with the test results.
community How essential is scalp biopsy when dealing with hair loss?
The user experienced hair loss despite using Fin and Min for 12 years and switched to Dutasteride, RU58841, and Keto scalp serum, but shedding and itch persist. They are considering increasing Dutasteride to 2.5mg and questioning the necessity of a scalp biopsy, with mixed opinions on its usefulness.
Related Research
6 / 6 resultsresearch Therapeutic strategies for treating hair loss
This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.
research An appraisal of laboratory models of androgenetic alopecia: A systematic review
This review evaluates laboratory models used in androgenetic alopecia research but reports no new findings, emphasizing the potential of human-derived 3-D models for future studies.
research A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
This source reports that scalp cooling is currently the only safe and FDA-cleared method to potentially reduce chemotherapy-induced hair loss, with about a 50% chance of maintaining sufficient hair to avoid needing a wig.
research Alcohol and Prostate Cancer: Time to Draw Conclusions
This review concludes that while many epidemiological studies suggest high alcohol intake is associated with an increased risk of prostate cancer, the evidence may be affected by confounding factors such as diet and lifestyle.
research E-Poster
In this case report from People's College of Medical Sciences, a 20-year-old man initially misdiagnosed with Addison's disease was ultimately found to have strongyloidiasis, with his symptoms and weight loss improving after antihelminthic treatment.
research Cutaneous manifestations of systemic infection in children
This review discusses diagnostic approaches for childhood skin diseases with fever through clinical observations and covers recent advances in understanding the pathogenesis and epidemiology of related infections, without reporting new clinical results.